ArticleBritish journal of pharmacology2013

The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.

A A Yarushkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.